PRESS RELEASES
December 10, 2025
Winter may feel cozy, but it’s also peak time for strokes – and mornings and Mondays aren’t far behind. Research shows that blood pressure spikes, holiday habits, and stress can all play a role.
Groundbreaking real-world data shows significant blood pressure reduction with Paradise™ uRDN System
December 10, 2025
Hypertension remains one of the leading preventable causes of cardiovascular disease worldwide, with 10–15% of patients suffering from resistant hypertension. New data presented at TCT 2025 highlight the powerful impact of Recor Medical’s Paradise™ Ultrasound Renal Denervation (uRDN) system.
December 10, 2025
This article is about the experience of how Dr. Ivan Javier Núñez-Gil built a successful uRDN Program in Spain. It is a powerful example for physicians and institutions looking to innovate and offer patients the latest therapeutic alternatives.
November 6, 2025
Data Presented at the 2025 TCT Conference from the Real-World Global Paradise System Registry Show a Significant and Meaningful BP Reduction at 6 Months.
September 22, 2025
(title to be announced soon)
September 22, 2025
Despite advances in hypertension treatment, nearly 75% of U.S. adults still struggle with uncontrolled blood pressure. A new nationwide analysis highlights the vast potential – and risks – of renal denervation (RDN) as a therapeutic option.
September 22, 2025
Renal denervation is gaining traction as a powerful tool in hypertension management—but it's not for everyone. Discover how ESC and ESH guidelines, clinical evidence, and practical tools like the Recor Medical selection form help identify the right candidates.
